These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9323277)

  • 1. Compliance with cyclosporine in adolescent renal transplant recipients.
    Blowey DL; Hébert D; Arbus GS; Pool R; Korus M; Koren G
    Pediatr Nephrol; 1997 Oct; 11(5):547-51. PubMed ID: 9323277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is noncompliance among adolescent renal transplant recipients inevitable?
    Feinstein S; Keich R; Becker-Cohen R; Rinat C; Schwartz SB; Frishberg Y
    Pediatrics; 2005 Apr; 115(4):969-73. PubMed ID: 15805372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of noncompliance in patients with a functioning renal transplant: a multicenter study. Compliance Study Group.
    Siegal B; Greenstein SM
    Transplant Proc; 1999; 31(1-2):1326-7. PubMed ID: 10083591
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a multivariate model predicting noncompliance with medication regimens among renal transplant patients.
    Greenstein S; Siegal B
    Transplantation; 2000 May; 69(10):2226-8. PubMed ID: 10852633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication compliance after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene RA
    Transplantation; 1995 Nov; 60(9):914-20. PubMed ID: 7491693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of noncompliance among renal transplant recipients.
    Frazier PA; Davis-Ali SH; Dahl KE
    Clin Transplant; 1994 Dec; 8(6):550-7. PubMed ID: 7865918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients.
    De Geest S; Abraham I; Moons P; Vandeputte M; Van Cleemput J; Evers G; Daenen W; Vanhaecke J
    J Heart Lung Transplant; 1998 Sep; 17(9):854-63. PubMed ID: 9773856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical noncompliance in South African black renal allograft recipients.
    Moshokoa ME; Ndlovu S; Modiba MC
    Transplant Proc; 2000 Nov; 32(7):1862-3. PubMed ID: 11119973
    [No Abstract]   [Full Text] [Related]  

  • 9. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation.
    Loghman-Adham M
    Am J Manag Care; 2003 Feb; 9(2):155-71. PubMed ID: 12597603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
    Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin in cyclosporine A-treated renal transplant patients.
    Grekas D; Bamichas G; Karamouzis M; Bacharaki D; Savidis N; Tourkantonis A
    Transplant Proc; 1999 May; 31(3):1703-5. PubMed ID: 10331044
    [No Abstract]   [Full Text] [Related]  

  • 12. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
    Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T
    Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance and noncompliance in kidney transplant patients: cues for transplant coordinators.
    Siegal B; Greenstein S
    J Transpl Coord; 1999 Jun; 9(2):104-8. PubMed ID: 10703391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A: peak or trough level monitoring in renal transplant recipients?
    Wacke R; Drewelow B; Kundt G; Hehl EM; Bast R; Seiter H
    Transplant Proc; 2001; 33(7-8):3122-3. PubMed ID: 11750342
    [No Abstract]   [Full Text] [Related]  

  • 16. Time-dependent difference of the 12-hour trough levels of cyclosporine in renal transplant recipients with sandimmune capsule.
    To H; Haba T; Uchida K; Fujimura A; Kobayashi E
    Transplant Proc; 2000 Feb; 32(1):221-2. PubMed ID: 10701028
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience.
    Maham N; Cardella C; Cattran D; Fenton S; O'Grady C; Hamill J; Smith R; Cole E
    Transplant Proc; 2001; 33(7-8):3098-9. PubMed ID: 11750331
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential utility of electronic drug compliance monitoring in measures of adverse outcomes associated with immunosuppressive agents.
    Feldman HI; Hackett M; Bilker W; Strom BL
    Pharmacoepidemiol Drug Saf; 1999 Jan; 8(1):1-14. PubMed ID: 15073941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplant patient compliance with free immunosuppressive medications.
    Chisholm MA; Vollenweider LJ; Mulloy LL; Jagadeesan M; Wynn JJ; Rogers HE; Wade WE; DiPiro JT
    Transplantation; 2000 Oct; 70(8):1240-4. PubMed ID: 11063348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of therapeutic drug monitoring services in renal transplant recipients treated with cyclosporine.
    Lee KL; Peng YL; Chou JL; Lee KT; Chung HM
    Transplant Proc; 2000 Nov; 32(7):1801-6. PubMed ID: 11119944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.